Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001010

Pres. Research & Development bought 1,706 shares at $2.69 ($4,589)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young David Pres. Research & Development 2026-04-30 Purchase +1,706 $2.69 $4,589 13,813 D
Open-market purchases · 1,706 sh · avg $2.69 · $4,589
Loading xslF345X06/form4.xml…